Measles virus takes a two-pronged attack on PP1.
1Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University Kita-ku, Kita-15, Nishi-7, Sapporo 060-8638, Japan.
Cell Host & Microbe
|July 11, 2014
Summary
Measles virus hinders the body's antiviral defenses by targeting protein phosphatase 1 (PP1). This prevents the activation of RIG-I-like receptors (RLRs), crucial for interferon production during viral infections.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- RIG-I-like receptors (RLRs) initiate antiviral responses.
- RLR activation requires dephosphorylation by protein phosphatase 1 (PP1).
- Type I interferons are key mediators of antiviral immunity.
Purpose of the Study:
- To investigate how measles virus interferes with the RLR-mediated antiviral pathway.
- To elucidate the mechanism by which measles virus evades host immune detection.
Main Methods:
- Cell-based assays to study RLR signaling.
- Analysis of protein-protein interactions between viral proteins and PP1.
- Measurement of interferon production in infected cells.
Main Results:
- Measles virus targets and inhibits PP1 activity.
- Inhibition of PP1 prevents RLR dephosphorylation and subsequent activation.
- This leads to suppressed type I interferon production, facilitating viral evasion.
Conclusions:
- Measles virus actively suppresses the innate immune system by targeting PP1.
- This viral strategy highlights a critical interaction between measles virus and host antiviral signaling pathways.
- Understanding this mechanism provides insights into viral pathogenesis and potential therapeutic targets.
